MedTrace Logo

Exploratory Clinical Study on the Safety of STR-P004

NCT07143617 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2026-03-09

No results posted yet for this study

Summary

This is an open-label, multiple-dose escalation IIT clinical study aimed at evaluating the safety, tolerability, PK, and preliminary efficacy of STR-P004 in adult patients with relapsed or refractory autoimmune diseases.

Conditions

Interventions

BIOLOGICAL

STR-P004

STR-P004 Intravenous infusion

Sponsors & Collaborators

  • Starna Therapeutics

    collaborator INDUSTRY

  • Beijing GoBroad Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-16
Primary Completion
2026-08-15
Completion
2026-09-14

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07143617 on ClinicalTrials.gov